The potential protective effects of taurine on coronary heart disease

Atherosclerosis

Volumn 208, Issue 1, 2010, Pages 19-25

  Wójcik, Oktawia P ^a   Koenig, Karen L ^a   Zeleniuch Jacquotte, Anne ^a   Costa, Max ^a   Chen, Yu ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidant; Blood pressure; Cholesterol; Coronary heart disease; Taurine

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BILE ACID CONJUGATE; TAURINE;

AMINO ACID METABOLISM; AMINO ACID TRANSPORT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; DIET; HEART PROTECTION; HUMAN; IN VITRO STUDY; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW;

ANIMALS; CORONARY DISEASE; HUMANS; TAURINE;

EID: 73449099588     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.06.002     Document Type: Review

References (50)

1. AHA. Heart disease and stroke statistics-2008 update at a glance (2008), American Heart Association, Dallas, Texas p. 1-43
2. Birdsall T.C. Therapeutic applications of taurine. Alt Med Rev 3 (1998) 128-136
3. Huxtable R.J. Expanding the circle 1975-1999: sulfur biochemistry and insights on the biological functions of taurine. Adv Exp Med Biol 483 (2000) 1-25
4. Schuller-Levis G., and Park E. Is taurine a biomarker?. Adv Clin Chem 41 (2006) 1-21
5. O'Flaherty L., Stapleton P.P., Redmond H.P., and Bouchier-Hayes D.J. Intestinal taurine transport: a review. Eur J Clin Invest 27 (1997) 873-880
6. Tappaz M.L. Taurine biosynthetic enzymes and taurine transporter: molecular identification and regulations. Neurochem Res 29 (2004) 83-96
7. Stapleton P.P., Charles R.P., Redmond H.P., and Bouchier-Hayes D.J. Taurine and human nutrition. Clin Nutr 26 (1997) 103-108
8. Finnegan D. The health effects of stimulant drinks. Br Nutr Foundation Nutr Bull 28 (2003) 147-155
9. Paauw J.D., and Davis A.T. Taurine supplementation at three different dosages and its effects on trauma patients. Am J Clin Nutr 60 (1994) 203-206
10. Yamori Y., Murakami S., Ikeda K., and Nara Y. Fish and lifestyle-related disease prevention: experimental and epidemiological evidence for anti-atherogenic potential of taurine. Clin Exp Pharmacol Physiol Suppl 31 (2004) S20-S23
11. Lam N.V., Chen W., Suruga K., Nishimura N., Goda T., and Yokogoshi H. Enhancing effect of taurine on CYP7A1 mRNA expression in Hep G2 cells. Amino Acids 30 (2006) 43-48
12. Yokogoshi H., Mochizuki H., Nanami K., Hida Y., Miyachi F., and Oda H. Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. J Nutr 129 (1999) 1705-1712
13. Murakami S., Kondo Y., Toda Y., et al. Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine. Life Sci 70 (2002) 2355-2366
14. Chen W., Matuda K., Nishimura N., and Yokogoshi H. The effect of taurine on cholesterol degradation in mice fed a high-cholesterol diet. Life Sci 74 (2004) 1889-1898
15. Mizushima S., Nara Y., Sawamura M., and Yamori Y. Effects of oral taurine supplementation on lipids and sympathetic nerve tone. Adv Exp Med Biol 403 (1996) 615-622
16. Zhang M., Bi L., Fang J.H., et al. Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects. Amino Acids 26 (2004) 267-271
17. Schaffer S.W., Lombardini J.B., and Azuma J. Interaction between the actions of taurine and angiotensin II. Amino Acids 18 (2000) 305-318
18. Kohashi N., Okabayashi Y., Hama J., and Katori R. Decreased urinary taurine in essential hypertension. Prog Clin Biol Res 125 (1983) 73-87
19. Yamamoto J., Akabane S., Yoshimi H., Nakai M., and Ikeda M. Effects of taurine on stress-evoked hemodynamic and plasma catecholamine changes in spontaneously hypertensive rats. Hypertension 7 (1985) 913-922
20. Fujita T., and Sato Y. Hypotensive effect of taurine. Possible involvement of the sympathetic nervous system and endogenous opiates. J Clin Invest 82 (1988) 993-997
21. Ideishi M., Miura S., Sakai T., Sasaguri M., Misumi Y., and Arakawa K. Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats. J Hypertens 12 (1994) 653-661
22. Militante J.D., and Lombardini J.B. Treatment of hypertension with oral taurine: experimental and clinical studies. Amino Acids 23 (2002) 381-393
23. Anuradha C.V., and Balakrishnan S.D. Taurine attenuates hypertension and improves insulin sensitivity in the fructose-fed rat, an animal model of insulin resistance. Can J Physiol Pharmacol 77 (1999) 749-754
24. Nara Y., Yamori Y., and Lovenberg W. Effect of dietary taurine on blood pressure in spontaneously hypertensive rats. Biochem Pharmacol 27 (1978) 2689-2692
25. Liu L., Liu L., Ding J., et al. Ethnic and environmental differences in various markers of dietary intake and blood pressure among Chinese Han and three other minority peoples of China: results from the WHO cardiovascular diseases and alimentary comparison (CARDIAC) study. Hepertens Res 24 (2001) 315-322
26. Mizushima S., Moriguchi E.H., Ishikawa P., et al. Fish intake and cardiovascular risk among middle-aged Japanese in Japan and Brazil. J Cardiovasc Risk 4 (1997) 191-199
27. Fujita T., Katsuyuki A., Noda H., Yasushi I., and Sato Y. Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension. Circulation 75 (1987) 525-532
28. Sethupathy S., Elanchezhiyan C., Vasudevan K., and Rajagopal G. Antiatherogenic effect of taurine in high fat diet fed rats. Indian J Exp Biol 40 (2002) 1169-1172
29. Kondo Y., Toda Y., Kitajima H., et al. Taurine inhibits development of atherosclerotic lesions in apolipoprotein E-deficient mice. Clin Exp Pharmacol Physiol 28 (2001) 809-815
30. Marcinkiewicz J., Grabowska A., Bereta J., Bryniarski K., and Nowak B. Taurine chloramine down-regulates the generation of murine neutrophil inflammatory mediators. Immunopharmacology 40 (1998) 27-38
31. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 326 (1993) 801-809
32. Casey R.G., Gang C., Joyce M., and Bouchier-Hayes D.J. Taurine attenuates acute hyperglycaemia-induced endothelial cell apoptosis, leucocyte-endothelial cell interactions and cardiac dysfunction. J Vasc Res 44 (2007) 31-39
33. Bedrosian I., Duane Sofia R., Wolff S.M., and Dinarello C.A. Tauroline, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells. Cytokine 3 (1991) 568-575
34. Park E., Quinn M.R., Wright C.E., and Schuller-Levis G. Taurine chloramine inhibits the synthesis of nitric oxide and the release of tumor necrosis factor in activated RAW 264.7 cells. J Leukoc Biol 54 (1993) 119-124
35. Milei J., Ferreira R., Llesuy S., Forcada P., Covarrubias J., and Boveris A. Reduction of reperfusion injury with preoperative rapid intravenous infusion of taurine during myocardial revascularization. Am Heart J 123 (1992) 339-345
36. Yamori Y., Liu L., Ikeda K., et al. Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC Study. Hypertens Res 24 (2001) 453-457
37. Yamori Y., Liu L., Mizushima S., Ikeda K., and Nara Y. Male cardiovascular mortality and dietary markers in 25 population samples of 16 countries. J Hypertens 24 (2006) 1499-1505
38. Lewington S., Clarke R., Qizilbash N., Peto R., and Collins R. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360 (2002) 1903-1913
39. Shao A., and Hathcock J.N. Risk assessment for the amino acids taurine, l-glutamine and l-arginine. Regul Toxicol Pharmacol 50 (2008) 376-399
40. Sturman J.A., Rassin D.K., and Gaull G. Taurine in the development of the central nervous system. In: Babeau A., and Huxtable R.J. (Eds). Taurine and neurological disorders (1978), Raven, New York 47-91
41. Hayes K.C., and Sturman J.A. Taurine in metabolism. Annu Rev 1 (1981) 401-425
42. Sole M.J., and Jeejeebhoy K.N. Conditioned nutritional requirements and the pathogenesis and treatment of myocardial failure. Curr Opin Clin Nutr Metab Care 3 (2000) 417-424
43. Hansen S.H. The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev 17 (2001) 330-346
44. Learn D.B., Fried V.A., and Thomas E.L. Taurine and hypotaurine content of human leukocytes. J Leukoc Biol 48 (1990) 174-182
45. Brosnan J.T., and Brosnan M.E. The sulfur-containing amino acids: an overview. J Nutr 136 (2006) p. S1636-S1640
46. Spaeth D.G., Schneider D.L., and Sarett H.P. Taurine synthesis, concentration, and bile salt conjugation in rat, guinea pig, and rabbit. Proc Soc Exp Biol Med 147 (1974) 855-858
47. Huxtable R.J. Physiological actions of taurine. Physiol Rev 72 (1992) 101-163
48. Laidlaw S.A., Grosvenor M., and Kopple J.D. The taurine content of common foodstuffs. J Parenter Enteral Nutr 14 (1990) 183-188
49. Pasantes-Morales H., Quesada O., Alcocer L., and Sãnchez Olea R. Taurine content in foods. Nutr Rep Int 40 (1989) 793-801
50. Lourenço R., and Camilo M.E. Taurine: a conditionally essential amino acid in humans? An overview in health and disease. Nutr Hosp 17 (2002) 262-270